Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
Suárez-Otero
R
R
Instituto de Seguridad Social de estado de México y Municipios, Toluca, Mexico.
Robles-San Román
M
M
Jaimes-Hernández
J
J
Oropeza-De La Madrid
E
E
Medina-Peñaloza
R M
RM
Rosas-Ramos
R
R
Castañeda-Hernández
G
G
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000068579:Celecoxib; D002792:Cholestyramine Resin / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004008:Diclofenac / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D010147:Pain Measurement; D011720:Pyrazoles; D013449:Sulfonamides / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000924:Anticholesteremic Agents; D016861:Cyclooxygenase Inhibitors; D004338:Drug Combinations; D011720:Pyrazoles; D013449:Sulfonamides; D002792:Cholestyramine Resin; D004008:Diclofenac; D000068579:Celecoxib